You can order now at www.cansativa.de

We enable cannabis.

Building the largest cannabis platform and offering the most desirable products and brands.

Our vision
cansativa®
cansativa®
cansativa®

Recently Seen On

vision

Building a flourishing future for cannabis.

We enable strong brands and provide access to high-quality medicinal products through our rapidly growing ecosystem.

As the central platform and trusted partner of the German Cannabis Agency (BfArM) our goal is to continually shape the industry with innovation and diversity.

Cansativa’s vision is built on trust, quality and high-friction transactions for our partners and customers setting the industry standards for excellence.

Our mission
vision
vision

Awarded By

Our experts for your business.

Cansativa provides elaborate knowledge within the industry with our diverse team of experts from various fields.

We develop a dependable and diversified product and service landscape alongside our international partners, governmental bodies, administrators and customers. 

Our team enables an innovative future for a new industry of enormous potential.

Founders
icon

Leading the industry with excellency

on average 20% market share with overall 2,5t distributed volume in 2022

icon

Providing brand & product portfolio variety

continuous portfolio expansion with 400+ SKU

icon

Connecting supply & customers

over 40+ international suppliers and 2k+ active customers

icon

Managing government contract

with over 10t exclusive contract value of domestic supply

icon

Innovating leading technologies

cannabis platform innovation for the industry

icon

Trailblazing

the cannabis

industry

with turnover of €13m+ in net revenue in 2022

We are pioneers, believers, executers, leaders -

and brothers. We are enablers.

– Benedikt & Jakob Sons, Founders & Managing Directors

With Jakob as a former lawyer and Benedikt as a former strategy consultant, our founders complement each other with their different professional backgrounds. They combine multi-faceted expertise and a strong entrepreneurial spirit with a common set of values, which is the key to our success. As a result, they are able to consider all aspects of the cannabis market and to act responsibly.

Together, they aim to become enablers of a potent young cannabis industry. They want to pave the way for young companies and make Germany the frontrunner of a safe European cannabis ecosystem.

“We are pioneers and strong executers since 2017. We have built the leading cannabis platform with the biggest supplier and customer network.

We are proud to offer the most desirable cannabis products and brands including the biggest multi-brand portfolio.”

icon

Benedikt Sons, Founder, Managing Director & CEO

„As the market leader in the medical cannabis industry and exclusive partner of the Federal Republic of Germany, we have shaped the German cannabis industry while meeting high regulatory standards.

We now strive to implement swift liberalization in a professional, safe, comprehensive and responsible manner."

icon

Jakob Sons, Founder & Managing Director

Policy

Public Affairs – fostering knowledge transfer between industry and public stakeholders.

Our public affairs team aspires to be a leader in responsibility and transparency in the public policy process regarding medicinal cannabis and the upcoming cannabis legalization for adult-use.

We are committed to open and transparent discussions that advance the discourse on facts, create a safe and better future for our partners, customers and patients in order to promote trust in the European cannabis industry. In addition to our focus on ethical business practices, we prioritize compliance with all relevant laws and regulations in the industry, including registering our lobbying activities and working in accordance with state code of conduct.

Find out more about current topics in our knowledge hub.

Press
icon

Public Affairs Contact

Receiving insights on most current topics.

Cansativa Group is the market leader in the medical cannabis market and sees itself as a driving force of the cannabis industry in Germany. Since the award by the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, they are the only company commissioned for the distribution of medical cannabis from German cultivation.

In the upcoming cannabis legalization, Cansativa Group sees itself as a pioneer in the democratization of the cannabis market.

Visit our press department for our mediakit.

30.10.2023 | Mörfelden-Walldorf

Cansativa and Cronos Group Inc. launch leading medical cannabis brand PEACE NATURALS® in Germany

Cronos Group Inc. (“Cronos”), a publicly traded global cannabis company, and Cansativa GmbH ("Cansativa"), the German market leader for medical cannabis, have entered into a supply agreement for the import, marketing, and distribution of the PEACE NATURALS® product line in Germany. The first of three products will be delivered to pharmacies on 1st of November 2023. Two further products will launch by November 2023. Pre-orders via the online shop of Cansativa are available for pharmacies now.
4.9.2023 | Frankfurt am Main

(German) Medizinalcannabis-Plattform Cansativa launcht neuen Onlineshop mit Fachportal

Mit einem neuen Onlineshop erleichtert Cansativa das Bestellen von cannabishaltigen Arzneimitteln und Cannabis-Blüten für Apotheken. Über das Fachportal sind kostenfreie Schulungen zum Thema Medizinalcannabis und Rezepturherstellung abrufbar.
1.6.2023 | Frankfurt am Main / Niederkassel

Cannalivery und Cansativa gehen strategische Partnerschaft ein, um die Versorgung mit Medizinalcannabis in Deutschland auszubauen

Die Cannabis-Onlineapotheke Cannalivery und Cansativa, Marktführer im medizinischen Cannabis-Markt, gehen ab sofort eine strategische Partnerschaft ein.Durch diese Zusammenarbeit wird dasstetig wachsende Partnernetzwerk genutzt, umdie Versorgung von Cannabis-Patient:innen in Deutschland zu verbessern. Eine der zentralen Verbesserungen, die aus der Partnerschaft hervorgehen, ist die schnelle Lieferung von einer noch größeren Produktauswahl von Cannabismedikamenten. Bereits jetzt garantiert Cannalivery eine Lieferzeit von nicht mehr als 48 Stunden. Das Ziel von Cannalivery, bereits 2024 innerhalb von 420 Minuten bundesweit auszuliefern, deckt sich mit dem Anspruch des Cansativa-Partnerprogramms, eine starke regionale Versorgung von Medizinalcannabis in Deutschland zu sichern.
icon

Press Contact